Login to Your Account



Epimmune Plans Acquisition Of Anosys For Synergistic Platform

By Aaron Lorenzo


Friday, February 14, 2003
The San Diego-based company entered a preliminary merger agreement with Anosys Inc. to create a combined entity focused on immunotherapeutics and products to treat cancer and infectious diseases. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription